Grant Bogle

Grant Bogle

Directeur/Membre du Conseil chez
Gladius Therapeutics, Inc.
68 ans
Health Technology
Health Services
Consumer Services

Profil

Grant C.
Bogle
is currently Director at Gladius Therapeutics, Inc., Myrobalan Therapeutics, Inc., and American School for the Deaf.
Former roles include President, Chief Executive Officer, CFO & Director at Epizyme, Inc. from 2021 to 2022; Independent Director at Nuvalent, Inc. from 2024 to 2026; Principal at EIDP, Inc., Roche Pharmaceuticals, Inc., Abbott India Ltd., and American Hospital Supply Corp.; Senior Vice President-Sales & Marketing at Millennium Pharmaceuticals, Inc.; EVP-Strategy & Emerging Businesses at US Oncology, Inc. from 2010 to 2011; Executive VP-Integrated Oncology Solutions at US Oncology Holdings, Inc.; Chief Commercial Officer & Senior Vice President at Tesaro, Inc. from 2015 to 2019; and Senior VP-Pharmaceutical & Biotech Solutions at McKesson Specialty Health, Inc. Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at Dartmouth College.

Postes actifs de Grant Bogle

SociétésPosteDébut
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Grant Bogle

SociétésPosteFin
NUVALENT, INC. Directeur/Membre du Conseil 15/07/2026
TESARO INC Corporate Officer/Principal 22/01/2019
EPIZYME, INC. Directeur Général -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Grant Bogle

Formation de Grant Bogle

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Process Industries

Health Technology

Health Services

Commercial Services

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Grant Bogle